BUSINESS

The rise of AI has rendered many pre-ChatGPT startups obsolete, highlighting a transformative shift in the tech landscape and investment priorities.

An experimental lung cancer drug by Akeso and Summit Therapeutics shows a 34% reduction in mortality risk, signaling potential industry shifts.

President Trump accelerates psychedelic drug research for mental health, creating new opportunities and risks in healthcare.

Lululemon settles its proxy battle with founder Chip Wilson, agreeing to appoint two new board nominees amid strategic vision concerns.

Disney plans to boost its advertising business under Rita Ferro, targeting Super Bowl, Oscars, and Grammys in 2027 for revenue growth.

Kohl’s sees a 20% stock surge as it reports improved sales trends despite a revenue decline, signaling potential recovery in retail.

Nick Bilton’s appointment as head of ’60 Minutes’ signals a strategic pivot to combat declining viewership and enhance CBS News’ impact.

Best Buy’s stock jumps 15% following a strong earnings report as the retailer focuses on overcoming its sales challenges.

Monthly auto loan payments over $1,000 are increasing, driven by popular pickup trucks rather than luxury vehicles. What does this mean for the market?

CVS announces coverage restoration for Zepbound and introduces Eli Lilly’s Foundayo, impacting healthcare choices for obesity treatment.